Antibiotic resistance in C. difficile by efflux has been previously suggested. The genome of C. difficile 630 was screened for sequences encoding putative proteins homologous to NorA from Staphylococcus aureus. Four ORFs homologous to efflux genes were cloned into the pAT79 shuttle vector under the control of transcription and translation signals of Gram-positive bacteria and expressed in Enterococcus faecalis JH2-2 and S. aureus RN4220. One of these sequences, designated cme conferred resistance to ethidium bromide, safranin O, and erythromycin in E. faecalis. The three other ORFs did not confer detectable resistance in both bacteria.
Introduction
Clostridium difficile is a leading cause of antibiotic-associated diarrhea and pseudomembranous colitis in humans [1] . Treatment of infections due to this bacterial species requires disruption of antibiotics that have contributed to the selection of C. difficile and therapy with either metronidazole or vancomycin. Colonization by this microorganism is due to the persistence of spores and to its antibiotic resistance. Resistance of C. difficile to chloramphenicol, erythromycin, and the tetracyclines is due to acquisition of genes usually born by transposons [2] . Resistance to fluoroquinolones is associated with mutations in gyrA and gyrB [3] . By contrast, multidrug resistance by efflux has not been documented, although the contribution of this mechanism has been suggested (F. Rafii, and R. Wynne, Abstr. ASM 101st General Meeting, abstr. A-59, Session No.119/A, 2001). Efflux pumps are ubiquitous in microorganisms and confer resistance to various molecules, including antibiotics, by extrusion of the drug. These transporters have been classified in two major groups on the basis of the energy source required. The ATP binding cassette transporters use ATP hydrolysis as source of energy whereas the proton-dependent multidrug efflux systems use the proton motive force (PMF) of the transmembrane electrochemical proton gradient. The latter group has been subdivided in four superfamilies that include the major facilitator (MF) superfamily [4] , the resistance-nodulation-division (RND) family [5] , the small multidrug resistance protein (SMR) [6] and, recently, the multidrug and toxic compound extrusion (MATE) superfamily [7] . The aim of this work was to detect putative efflux pumps by analysis of the genome of C. difficile (The Wellcome Trust Sanger Institute, www.sanger.ac.uk). Our research focused on the MF superfamily since it contains members able to confer fluoroquinolone resistance such as NorA from Staphylococcus aureus [8] , Bmr from Bacillus subtilis [9] , and PmrA from Streptococcus pneumoniae [10] . Attempts to transform C. difficile have until now been unsuccessful or not clearly demonstrated making gene discontinuation difficult. We therefore, cloned and expressed in Enterococcus faecalis JH2-2 [11] S. aureus RN4220 [12] and Escherichia coli AG100A [13] genes homologous to those for efflux pumps in other bacterial genera.
Materials and methods

Computer analysis of C. difficile genome
Sequence from the Wellcome Trust Sanger Institute (http://www.sanger.ac.uk) C. difficile strain 630 genome project was screened against the NorA efflux determinant by using the Blast [14] and the Fasta [15] softwares. Five open reading frames (ORF) of the C. difficile genome designated 1-5 were homologous to norA. ORF1 and ORF2 were contiguous and likely to originate from a single ORF split by a stop codon. The 3 0 -end of ORF2 not available in the database was characterized by inverse PCR. A similar approach was used at the amino acid level to detect C. difficile translated sequences similar to the conserved domains of efflux pumps. Alignment of the deduced proteins was obtained by using ClustalW software [16] (see Figs. 1 and 2 ).
Plasmids, strains, and growth conditions
The bacteria and plasmids used in this study are listed in Table 1 . C. difficile strains were grown anaerobically on pre-reduced and pre-warmed trypticase glucose yeast extract broth, pH 7.8 (Difco laboratories, Detroit, MI) at 37°C. Competent E. coli Top10 (Invitrogen Corp., San Diego, CA) and AG100A were grown on LuriaBertani agar medium (Difco Laboratories) containing kanamycin (0.05 mg/ml) or spectinomycin (0.1 mg/ml) for selection of transformants. E. faecalis JH2-2 and Fig. 1 . Alignment of the Cme protein from C. difficile with MefA from S. pyogenes and MefE from S. pneumoniae. The dashes indicate gaps introduced to optimize sequence similarity. The alignment was derived with the ClustalW program [16] . Identical aminoacids are indicated by asterisks, highly isofunctional aminoacids are indicated by two dots, isofunctional aminoacids are indicated by dots. The consensus 13 residu motif [4] 
is underlined and the conserved amino acids are in bold.
S. aureus RN4220 were grown on brain heart infusion broth and agar (Difco Laboratories) supplemented with spectinomycin (0.06 mg/ml) for selection of transformants.
DNA manipulations
Total DNA from C. difficile 630 was prepared by using the Puregene Ò DNA isolation kit (Gentra Systems, Minneapolis, Ind). Purification of plasmid DNA was performed by using the GenElute ä Plasmid Miniprep Kit (Sigma-Aldrich, Steinheim, Germany). Restriction by endonucleases was according to the supplierÕs recommendations (Amersham Bioscience, Buckinghamshire, UK). Extraction of DNA fragments separated by low melting agarose (Sigma-Aldrich) gel electrophoresis was carried out using the High Pure purification kit (Roche Diagnostics GmbH, Mannheim, Germany). PCR was performed in a GeneAmp PCR system 2400 (Perkin-Elmer Cetus, Norwalk, Conn.) with ThermalAce ä DNA polymerase (Invitrogen Corp.) or Taq polymerase (Amersham Bioscience) according to the manufacturerÕs recommendations. Annealing steps were performed at 45 or 52°C with specific primers (Eurobio, Les Ulis, France), oligodeoxynucleotides P3 and P3Rev were used for amplification of ORF3, P4 and P4Rev for ORF4, P5 and P5Rev for ORF5, 341B and 341D for the 3 0 -end of ORF2, P1 and P1Rev for ORF1.2, and Mut1 and Mut2 for site directed mutagenesis ( Table 2 ). The 3 0 -end of ORF2 from C. difficile 630 was obtained by inverse PCR using Dra I and sequenced. Primers P1 and P1Rev were used to amplify contiguous ORF1 and ORF2. To generate a unique ORF similar in size to norA, directed mutagenesis was performed by mutation of the TGA stop codon at position 66. PCR amplification was obtained with ThermalAce ä DNA polymerase (Invitrogen Corp.). The amplification products were mixed and used as targets for a second amplification Fig. 2 . Alignment of the putative protein ORF1-ORF2 G196 from C. difficile with NorA from S. aureus, PmrA from S. pneumoniae, and Bmr from B. subtilis. The dashes indicate gaps introduced to optimize sequence similarity. The alignment was derived with the ClustalW program [16] . Identical aminoacids are indicated by asterisks, highly isofunctional aminoacids are indicated by two dots, isofunctional aminoacids are indicated by dots. The Glycine wich was introduced is in bold.
cycle with the P1 and P1Rev primers. The resulting fragment was cloned in the pCR-Blunt Ò vector (Invitrogen Corp.) according to the supplierÕs recommendation and sequenced.
Cloning and sequencing of putative efflux genes
The PCR products were cloned in the pCR-Blunt Ò vector (Zero Blunt cloning kit, Invitrogen Corp.) and transformed into E. coli Top10 according to the supplierÕs recommendation. Selection of transformants was on LB plates containing kanamycin and X-Gal. Transformants were screened for the presence of an insert by electrophoresis on agarose gel of plasmid DNA restricted by EcoRI (Amersham Pharmacia Biotech). Recombinant plasmids were digested by SacI and XbaI (Amersham Pharmacia Biotech) to extract the cloned fragments separated by low melting agarose gel electrophoresis. The SacI-XbaI fragments were cloned into pAT79 [17] and transformed into E. coli Top10 (Invitrogen Corp.) with selection on spectinomycin. Plasmid DNA from transformants was screened on agarose gel electrophoresis. Electrotransformation of E. faecalis JH2-2, S. aureus RN4220 and, E. coli AG100A with pAT79 DNA was performed as described [18] [19] [20] . All the constructions in pAT79 were analysed by sequencing with an ABI PRISM 310 automated DNA sequencing apparatus (Perkin-Elmer Applied Biosystems).
Susceptibility testing
Susceptibility to ethidium bromide, safranin O, acriflavin, acridin O, benzalkonium chloride, cetrimide, biliary salts, norfloxacin, tetracycline, erythromycin and lincomycin was screened on Brain Heart agar drug gradient plates [21] . The MICs of the substrates detected by this method were determined on Brain Heart agar plates containing ethidium bromide concentrations increasing by 0.0005 mg/ml from 0.001 to 0.01 mg/ml. For safranin O the scale was from 0.01 to 0.05 mg/ml and the increments of 0.0002 mg/ml. For erythromycin the scale was from 0.00001 to 0.0002 mg/ml increasing by 0.00001 mg/ml per plate. All the MICÕs were determined in duplicate with or without addition of 0.02 mg/ml of reserpine (Sigma-Aldrich Gmbh) in three independant experiments. The MICs of the substrates against C. difficile 630 were determined on Wilkins Chalgren agar (Oxoid Limited, Basingstoke, UK) plates under anaerobic conditions with or without addition of reserpine.
Nucleotide sequence Accession Number
The nucleotide sequences of orf1-orf2 G196 , lacCd, linCd, and cme have been deposited in the GenBank data library, respectively, under Accession Nos. AY362983, AY362980, AY362982 and, AY362981.
Results and discussion
Detection of sequences in C. difficile 630 homologous to those of efflux pumps
Sequences from C. difficile likely to encode members of the MF superfamily were screened for by the same process at that for identification of pmrA in S. pneumoniae [10] . Four sequences for potential multidrug resistance transporters were identified in the C. difficile genome by use of BLAST [14] and FASTA [15] algorithms. Contiguous ORFs (ORF1 and ORF2) for the first pump were designated orf1-orf2. ORF3, ORF4, and ORF5 were, respectively, named cme (for ''Clostridium multidrug efflux''), lacCd and linCd due to similarity with ypfE from Lactococcus lactis and the lincomycin resistance gene lmrB from B. subtilis (Table 3) .
Characterization of ORF1/ORF2 sequences
The 3 0 -end of ORF2 located at the end of a contig was not available in the databank and was thus amplified by inverse PCR and sequenced. The stop codon of ORF1 disrupted a large ORF1-ORF2 open reading frame similar in size to norA. To determine if the split resulted from a nonsens mutation in strain 630, we sequenced a 300-bp PCR fragment overlaping the stop codon in ORF1 in five others C. difficile from various origins. In the six strains studied the stop codon was present, disrupting proteins homologous to NorA from S. aureus and PmrA from S. pneumoniae. This suggests that orf1-orf2 was inherited from an ancestor in another bacterium, and that either its product was toxic for the cell or of no advantage to C. difficile. Another explanation was that the mutation arose from a common C. difficile ancestor of all these strains; it is also possible that there could be some ribosomal read through the stop codon. The nucleic acid alignment indicated a low level of polymorphism (94.6% of identity) and the presence of an Ochre codon at position 66 in all strains (data not shown).
Reconstruction of a single orf1-orf2 ORF
Because of lack of detectable function of ORF1/ ORF2, both ORFs were fused to generate a single ORF. This was obtained by a TGA ! GGA transversion leading to the Ochre 66 ! Glycine change which is present at this position in NorA. The 1211-bp sequence designated orf1-orf2 G196 was cloned in pAT79 [17] .
Cloning of the putative efflux genes in a shuttle vector
The orf1-orf2, orf1-orf2 G196 , cme, lacCd and linCd sequences were cloned in pAT79 to study their functionality into electrotransformable E. faecalis JH2-2 [18] , S. aureus RN4220 [19] and E. coli AG100A [20] . The genome of these bacteria are characterized and several efflux systems associated with intrinsic resistance have been identified.
Search for antibiotic efflux
The resistance conferred by these genes was studied by comparing E. faecalis JH2-2, E. faecalis JH2-2 (pAT79), E. faecalis JH2-2(pAT79Xorf1-orf2), E. faecalis JH22 (pAT79 Xorf1-orf2 G196 ), E. faecalis JH2-2 (pAT79X cme), E. faecalis JH2-2 (pAT79X lacCd), and E. faecalis JH2-2 (pAT79X linCd) on Brain Heart drug gradient plates. The orf1-orf2 G196 , lacCd and linCd putative efflux genes cloned in pAT79 did not confer to E. faecalis JH2-2 any detectable resistance to various compounds including benzalkonium chloride, cetrimid, acriflavin, acridine O, clindamycin, lincomycin, tetracycline, and norfloxacin (data not shown). By contrast, the cme gene conferred reproducible resistance to ethidium bromide, safranin O, and erythromycin to E. faecalis JH2-2 as shown in six independent experiments (Fig. 3) . Efflux pumps are in general stringently regulated and their function can only be studied in regulatory mutants overexpressing the pump [22] . Reserpine selectively inhibits efflux pumps that require proton motive force [23] and the multidrug resistance due to the cme gene in E. faecalis (Table 4) . As already mentioned, C. difficile is not transformable and gene inactivation cannot be performed in strain 630. However, the fact that reserpine enhanced the susceptibility of C. difficile 630 to safranin O (MIC = 0.25 mg/ml in the presence of reserpine instead of 0.40 mg/ml) and ethidium bromide (MIC = 0.016 mg/ml instead of 0.028 mg/ml), suggests that these compounds were extruded by an endogenous PMF dependent pump, which could be Cme. Reserpine could not detect efflux of erythromycin in strain 630 because the presence of two copies of the ermB gene which confers high levels resistance to this antibiotic [24] . Several efflux pumps have been characterized in E. faecalis and the resistance conferred by orf1-orf2 G196 , lacCd, and linCd in E. faecalis JH2-2 could be masked by intrinsic resistance of the new host; although, generally, combination of mechanisms provide additive effects [25] .
Similarly, properties conferred by the four putative efflux genes of C. difficile were studied by comparing S. aureus RN4220, S. aureus RN4220 (pAT79), S. aureus RN4220 (pAT79Xorf1-orf2), S. aureus RN4220 (pAT79Xorf1-orf2 G196 ), S. aureus RN4220 (pAT79 Xcme), S. aureus RN4220 (pAT79XlacCd), and S. aureus RN4220 (pAT79XlinCd) on Brain Heart drug gradient plates. None of these plasmids conferred resistance to antibiotics and dyes listed above in S. aureus (data not shown). Loss of resistance to Safranin O, ethidium bromide and erythromycin in S. aureus RN42220 cannot result of defective transcription, since chloramphenicol resistance was conferred by the cat gene of pAT79Xcme acting as a reporter gene. Although, few pumps have been reported inactive in an heterologous host, the difference of expression of cme in E. faecalis and S. aureus remains unexplained. E. faecalis JH2-2 is naturally resistant to lincomycin, thus resistance conferred to this antibiotic by the putative efflux gene of C. difficile was studied in S. aureus RN4220 on lincomycin gradient plates. However, lincomycin resistance by efflux was not detected when the putative efflux genes of C. difficile were cloned in this microorganism (data not shown). Few efflux genes from Gram-positive bacteria have been reported to confer resistance in Gram-negative microorganisms, but, pAT79Xorf1-orf2, pAT79-Xorf1-orf2 G196 , pAT79X cme, pAT79XlacCd, and, pAT79XlinCd did not conferred detectable resistance to antibiotics and basic dyes to E. coli AG100A deleted for AcrAB efflux systems (data not shown). In this work we thus considered more appropriate to clone the putative C. difficile efflux genes both into E. faecalis and S. aureus RN4220 to detect their function. This, led to the demonstration that among the four putative efflux Fig. 3 . E. faecalis JH2-2 (pAT79Xcme); 2, E. faecalis JH2-2 (pAT79). Strains were grown for 24 h at 37°C in BHI agar containing a drug gradient as indicated.
pumps of C. difficile, studied here, only cme conferred multidrug resistance in E. faecalis. However, the three other efflux genes did not express in E. coli, E. faecalis nor S. aureus; thus absence of detectable activity can be misleading. Moreover, there are numerous substrates for the efflux pumps and the compounds we tested may have been inappropriate. In conclusion, this work represents a contribution to the study of efflux in C. difficile but the role of this mechanism to antibiotic resistance in this species remains to be established. 
